Teleflex Incorporated ( TFX ) Nowojorska Giełda Papierów Wartościowych

Cena: 116.58 ( 1.2% )

Aktualizacja 07-23 16:18
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Instruments & Supplies

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Instruments & Supplies
Zatrudnienie: 14 500
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 99.7215
Ilość akcji: Brak danych
Debiut giełdowy: 1980-03-17
WWW: https://www.teleflex.com
CEO: Mr. Liam J. Kelly
Adres: 550 East Swedesford Road
Siedziba: 19087-1603 Wayne
ISIN: US8793691069
Opis firmy:

Teleflex obejmuje projekty, rozwija, produkuje i dostarcza jednorazowe urządzenia medyczne do wspólnych procedur diagnostycznych i terapeutycznych w zakresie opieki krytycznej i zastosowań chirurgicznych na całym świecie. Zapewnia produkty dostępu naczyniowego, które zawierają cewniki marki strzałek, systemy nawigacji cewnika i pozycjonowania końcówek oraz systemy dostępu wewnątrzkostkowego do podawania terapii dożylnych, pomiaru ciśnienia krwi i odstawienia próbek krwi przez jedno miejsce nakłucia. Firma oferuje również produkty interwencyjne, które składają się z różnych cewników wieńcowych, strukturalnych terapii serca oraz interwencji peryferyjnych i produktów asystenta serca, które są używane przez kardiologów i radiologów interwencyjnych oraz chirurgów naczyniowych; oraz cewniki Arrow, wytyczne i cewniki Trapliner, zamykanie naczyniowe Manta i urządzenia strzałkowe OnControl. Zapewnia produkty anestezjologiczne, takie jak produkty do zarządzania dróg oddechowych i bólu do wspierania szpitali, medycyny ratunkowej i kanałów wojskowych; oraz produkty chirurgiczne, w tym klipy ligacji metali i polimeru oraz układy chirurgiczne zamknięcia powięzi, które są stosowane w laparoskopowych zabiegach chirurgicznych, przezskórnych układach chirurgicznych i innych instrumentach chirurgicznych. Firma oferuje również interwencyjne produkty urologii obejmujące system Urolift, inwazyjną technologię leczenia niższych objawów dróg moczowych z powodu łagodnego przerostu prostaty; oraz produkty oddechowe, w tym terapie tlenowe i aerozolowe, spirometria i produkty do zarządzania wentylacją do stosowania w różnych warunkach opieki. Zapewnia produkty urologii, takie jak cewniki, kolekcjonerki moczu oraz akcesoria cewnikowania i produkty do endurologii operacyjnej; i usługi zarządzania pęcherzami. Firma obsługuje szpitale i świadczeniodawców, producentów urządzeń medycznych i rynków opieki domowej. Firma została zarejestrowana w 1943 roku i ma siedzibę w Wayne w Pensylwanii.

Wskaźniki finansowe
Kapitalizacja (USD) 5 151 774 565
Aktywa: 7 486 291 000
Cena: 116.58
Wskaźnik Altman Z-Score: 3.2
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 1
P/E: 36.1
Ilość akcji w obrocie: 100%
Średni wolumen: 563 224
Ilość akcji 44 189 000
Wskaźniki finansowe
Przychody TTM 3 025 824 000
Zobowiązania: 3 004 574 000
Przedział 52 tyg.: 108.9 - 249.91
Piotroski F-Score: 7
Silny (dobra jakość finansowa)
EPS: 3.2
P/E branży: 29.9
Beta: 1.177
Raport okresowy: 2025-07-31
WWW: https://www.teleflex.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Daniel V. Logue Corporate Vice President, General Counsel & Secretary 720 274 1974
Mr. Cameron P. Hicks Corporate Vice President & Chief Human Resources Officer 564 684 1965
Mr. Liam J. Kelly Chairman, President & Chief Executive Officer 2 628 759 1967
Mr. Thomas E. Powell BS, MBA Executive Vice President & Chief Financial Officer 1 288 010 1962
Mr. Jay White Corporate Vice President & President of Global Commercial 1 089 020 1974
Mr. Timothy F. Duffy Vice President & Chief Information Officer 0 0
Mr. Howard Cyr Corporate Vice President & Chief Compliance Officer 0 0
Mr. James Ferguson President & GM of Surgical 0 0
Mr. John R. Deren Corporate Vice President & Chief Accounting Officer 0 0
Ms. Michelle Fox Corporate Vice President & Chief Medical Officer 0 0
Lista ETF z ekspozycją na akcje Teleflex Incorporated
Symbol ETF Ilość akcji Wartość
IJR 2 699 154 314 910 275
VB 1 171 420 143 229 523
SCYB 890 000 876 048
VBR 753 100 92 081 537
IJS 425 672 49 663 179
SPSM 373 292 44 180 856
BBHY 373 000 369 277
XHY.TO 265 000 353 477
SLYV 248 981 29 439 308
IHI 236 926 27 642 105
GHYB 197 000 196 184
IWR 160 298 18 702 002
VIOO 157 082 19 206 416
XHY.TO 150 000 203 728
VHT 139 716 17 083 075
DFAT 123 928 14 858 967
SCHM 116 827 14 007 557
DFSV 104 174 12 490 462
IWD 102 482 11 956 547
FXH 101 700 11 865 339
DFAS 95 987 11 508 841
VIOV 94 296 11 529 571
BBHY 93 000 90 860
IWS 66 930 7 808 727
ISP6.L 66 703 7 782 229
IDP6.L 66 703 7 782 229
IUS3.DE 66 703 7 782 229
ITOT 57 339 6 689 700
PSCH 44 414 5 325 238
SCHX 44 312 5 313 008
IWB 32 808 3 827 687
JHMM 29 299 3 786 602
RWJ 26 941 3 230 225
WSML.L 26 913 3 139 941
WLDS.L 26 913 3 139 941
IUSN.DE 26 913 3 139 941
VONV 24 976 3 053 815
XHE 24 839 3 000 111
IYH 24 663 2 877 480
FNDX 24 631 2 953 256
CUSS.L 23 527 2 744 870
CSUSS.MI 23 527 2 744 870
CUS1.L 23 527 2 744 870
SXRG.DE 23 527 2 744 870
SCHV 22 646 2 715 255
BBMC 21 642 2 561 547
SMMV 21 283 2 551 831
DFAC 20 123 2 412 747
FSMD 19 250 2 340 607
FHLC 19 196 2 334 041
SMLF 17 975 2 097 170
DFUV 16 894 2 025 590
SFLO 16 216 1 944 298
IJR.AX 15 400 2 758 042
ESML 15 166 1 818 403
IWV 13 073 1 525 247
RECS 12 735 1 526 926
WSCR.L 11 775 1 411 775
DFUS 10 874 1 303 792
SMMD 10 326 1 238 087
ESGV 10 176 1 406 221
PRF 9 309 1 116 149
ISCV 8 963 1 045 767
SPTM 8 621 1 005 813
TILT 7 904 940 022
DSMC 7 808 936 179
DFAU 7 559 906 324
QVMS 7 533 903 206
VONE 7 055 862 614
AVUS 6 653 797 694
FNX 6 648 775 622
UMDV.AS 6 265 730 910
ONEV 5 916 693 572
VFVA 4 824 666 628
EQAL 4 798 575 280
IQSM 4 685 561 731
CZA 4 665 559 333
ONEY 4 050 483 842
VTHR 3 610 441 394
XJR 3 465 415 453
SCHK 3 332 394 375
VVL.TO 2 684 533 820
ISCB 2 201 256 825
XEQT.TO 2 074 330 069
IYY 2 044 238 481
AGNG 2 014 239 525
JVAL 1 935 229 026
XUU.TO 1 875 305 459
JPME 1 578 186 772
XSMC.TO 1 567 249 360
GUSA 1 508 180 809
XSMH.TO 1 488 236 788
XAW.TO 1 430 227 697
JHSC 1 416 183 003
IHHY.AX 1 406 212 390
IUS 1 399 167 740
FNDB 1 139 134 812
DCOR 918 110 068
GHYC.SW 826 99 086
AVMC 816 97 838
DXUV 663 79 493
PINK 655 79 641
V3AL.L 632 77 274
V3AA.L 632 77 274
REVS 628 75 297
VLU 606 70 948
GVUS 573 68 702
AVLC 527 63 187
CAFG 515 61 748
JUST 430 51 557
FLOW 366 43 528
ESIX 340 40 145
DFSU 339 40 646
R1VL.L 336 39 201
XBAL.TO 320 52 057
AVSU 308 36 929
MDEV 288 33 600
AFMC 285 33 250
USFM.L 283 33 950
USUE.DE 283 33 950
MFUS 274 32 430
XUH.TO 268 31 253
MAGA 235 98 127
STXM 231 27 696
STXV 174 20 862
GHYC.SW 162 19 463
IHHY.AX 157 23 399
DEUS 116 13 908
ONEO 94 10 950
XTR.TO 91 12 181
GVLU 65 0
XTR.TO 52 6 992
STXG 46 5 515
XSC.TO 45 5 977
XSC.TO 42 5 627
XTR.TO 11 1 328
MMTM 6 699
PXS.TO 0 0
IE00BN4Q0370.SG 0 0
DWSH -982 -117 741
Wiadomości dla Teleflex Incorporated
Tytuł Treść Źródło Aktualizacja Link
Lost Money on Teleflex Incorporated (TFX)? Possible Fraud - Contact Levi & Korsinsky Today NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated ("Teleflex Incorporated") (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal. accessnewswire.com 2025-05-15 21:30:00 Czytaj oryginał (ang.)
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / WHY: New York, N.Y., May 15, 2025. accessnewswire.com 2025-05-15 21:00:00 Czytaj oryginał (ang.)
TFX ALERT: Ongoing Investigation Into Teleflex Incorporated - Contact Levi & Korsinsky NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated ("Teleflex Incorporated") (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal. accessnewswire.com 2025-05-15 14:30:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-15 14:00:00 Czytaj oryginał (ang.)
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH 1 -2 globenewswire.com 2025-05-15 10:30:00 Czytaj oryginał (ang.)
Investors in Teleflex Incorporated (TFX) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated ("Teleflex Incorporated") (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal. accessnewswire.com 2025-05-14 19:30:00 Czytaj oryginał (ang.)
Ongoing Securities Investigation into Teleflex Incorporated (TFX) - Contact Levi & Korsinsky NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated ("Teleflex Incorporated") (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal. accessnewswire.com 2025-05-14 16:15:00 Czytaj oryginał (ang.)
Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-14 14:00:00 Czytaj oryginał (ang.)
ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / WHY: New York, N.Y., May 13, 2025. accessnewswire.com 2025-05-13 21:31:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-13 14:00:00 Czytaj oryginał (ang.)
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy Data also demonstrate significantly lower rates of postoperative reflux and decreased incidence of de novo gastroesophageal reflux disease (GERD) without affecting total weight loss at 1-year*, and shorter average hospital length of stay (LOS) associated with use of the Titan SGS™ Stapler compared with multi-fire staplers 1 globenewswire.com 2025-05-13 10:30:00 Czytaj oryginał (ang.)
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX NEW YORK , May 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public. So What: If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2025-05-12 18:10:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-12 14:00:00 Czytaj oryginał (ang.)
Teleflex Announces Quarterly Dividend WAYNE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 16, 2025, to shareholders of record at the close of business on May 20, 2025. globenewswire.com 2025-05-12 10:30:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect NEW YORK CITY, NY / ACCESS Newswire / May 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-11 14:00:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / May 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-09 14:00:00 Czytaj oryginał (ang.)
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / WHY: New York, N.Y., May 8, 2025. accessnewswire.com 2025-05-08 21:45:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-08 14:00:00 Czytaj oryginał (ang.)
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX NEW YORK , May 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public. So What: If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2025-05-07 22:08:00 Czytaj oryginał (ang.)
Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX. accessnewswire.com 2025-05-07 14:00:00 Czytaj oryginał (ang.)
TFX STOCK NOTICE: Teleflex Incorporated Investors with Losses are Notified of an Ongoing Securities Fraud Investigation; Contact BFA Law NEW YORK CITY, NY / ACCESS Newswire / February 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Teleflex Incorporated (NYSE:TFX) for potential violations of the federal securities laws. If you invested in Teleflex, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/teleflex-incorporated. accessnewswire.com 2025-02-27 17:38:00 Czytaj oryginał (ang.)
Teleflex Incorporated (TFX) Q4 2024 Earnings Call Transcript Teleflex Incorporated (NYSE:TFX ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Lawrence Keusch - VP-IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas Powell - EVP & CFO John Deren - Corporate VP and Chief Accounting Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group Richard Newitter - Truist Securities Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. seekingalpha.com 2025-02-27 17:20:15 Czytaj oryginał (ang.)
TFX BREAKING NEWS: Teleflex Incorporated 20% Stock Drop Triggers Securities Fraud Investigation; Investors are Urged to Contact BFA Law if they Suffered Losses NEW YORK--(BUSINESS WIRE)---- $TFX #ClassAction--Teleflex Incorporated investors that lost money are encouraged to contact BFA Law about its ongoing securities fraud investigation. businesswire.com 2025-02-27 15:47:00 Czytaj oryginał (ang.)
Teleflex Hits 52-Week Low On Plan To Split Into Two Companies, Reports Mixed Q4 Earnings On Thursday, Teleflex Incorporated TFX will pursue a plan to separate into two new, independent, publicly traded companies: benzinga.com 2025-02-27 13:34:59 Czytaj oryginał (ang.)
Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-27 12:36:08 Czytaj oryginał (ang.)
Teleflex (TFX) Surpasses Q4 Earnings Estimates Teleflex (TFX) came out with quarterly earnings of $3.89 per share, beating the Zacks Consensus Estimate of $3.86 per share. This compares to earnings of $3.38 per share a year ago. zacks.com 2025-02-27 10:50:27 Czytaj oryginał (ang.)
Medical device maker Teleflex to split into two Teleflex said on Thursday it would split into two by spinning off its business that makes devices for the urology, and acute care markets as well as its contract manufacturing unit. reuters.com 2025-02-27 09:17:20 Czytaj oryginał (ang.)
Teleflex Announces Quarterly Dividend WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 17, 2025, to shareholders of record at the close of business on March 7, 2025. Additional information about Teleflex can be obtained from the company's website at teleflex.com. globenewswire.com 2025-02-27 08:45:00 Czytaj oryginał (ang.)
Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2024. globenewswire.com 2025-02-27 08:39:00 Czytaj oryginał (ang.)
Teleflex Announces Planned Retirement of Thomas Powell As Chief Financial Officer John Deren To Be Named Executive Vice President and Chief Financial Officer John Deren To Be Named Executive Vice President and Chief Financial Officer globenewswire.com 2025-02-27 08:36:00 Czytaj oryginał (ang.)
Teleflex Announces Intent to Separate into Two Publicly Traded Companies WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that following a comprehensive business portfolio evaluation, its Board of Directors has authorized Teleflex management to pursue a plan to separate the company's Urology, Acute Care, and OEM businesses into a new, independent, publicly traded company via a distribution of newly issued shares of NewCo to shareholders that is tax-free for U.S. tax purposes. globenewswire.com 2025-02-27 08:33:00 Czytaj oryginał (ang.)
Teleflex to Acquire BIOTRONIK's Vascular Intervention Business WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million, less certain adjustments as provided in the purchase agreement including certain working capital not transferring and other customary adjustments. The acquisition is subject to customary closing conditions, including receipt of certain regulatory approvals, and is expected to be completed by the end of the third quarter of 2025. globenewswire.com 2025-02-27 08:30:00 Czytaj oryginał (ang.)
Insights Into Teleflex (TFX) Q4: Wall Street Projections for Key Metrics Get a deeper insight into the potential performance of Teleflex (TFX) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-02-24 12:21:24 Czytaj oryginał (ang.)
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference WAYNE, Pa., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the Raymond James & Associates 46th Annual Institutional Investors Conference at the JW Marriott Grande Lakes, Orlando, FL, on Tuesday, March 4, 2025, at 3:25 p.m. (ET). globenewswire.com 2025-02-18 08:30:00 Czytaj oryginał (ang.)
Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information WAYNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 27, 2025. globenewswire.com 2025-02-13 08:30:00 Czytaj oryginał (ang.)
Teleflex awarded Short Term Central Venous Catheters contract from Vizient WAYNE, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been awarded a contract by Vizient, Inc., the largest provider-driven healthcare performance improvement company in the U.S. The agreement, effective January 1, 2025, covers the supply of Teleflex's Central Venous Access Catheters and Arterial Catheters. Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for more than 65% of the nation's acute care providers. globenewswire.com 2025-01-09 08:30:00 Czytaj oryginał (ang.)
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference WAYNE, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 14, 2025, at 5:15 p.m. (PT). globenewswire.com 2025-01-07 08:30:00 Czytaj oryginał (ang.)
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX) NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible violations of state laws. If you own Teleflex stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy. businesswire.com 2025-01-06 16:43:00 Czytaj oryginał (ang.)
Here's Why Teleflex (TFX) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com 2024-12-23 12:46:38 Czytaj oryginał (ang.)
Should You Retain Teleflex Stock in Your Portfolio Right Now? TFX stays on investors' radars due to its performance in the Vascular Access segment and expansion moves. zacks.com 2024-12-23 12:31:29 Czytaj oryginał (ang.)
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain? Teleflex introduces the Arrowg+ard Blue Plus MSB Procedure Kit in the EMEA. zacks.com 2024-12-16 10:16:08 Czytaj oryginał (ang.)
Why Teleflex (TFX) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-12-06 12:45:27 Czytaj oryginał (ang.)
Here's Why Teleflex (TFX) is a Strong Growth Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-11-21 12:50:45 Czytaj oryginał (ang.)
Here's Why Teleflex (TFX) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-11-19 12:46:03 Czytaj oryginał (ang.)
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference WAYNE, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 36th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, December 3, 2024, at 9:30 a.m. (ET). globenewswire.com 2024-11-19 08:30:00 Czytaj oryginał (ang.)
Teleflex to Present at the Jefferies London Healthcare Conference WAYNE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Thursday, November 21, 2024, at 9:30 a.m. (GMT). globenewswire.com 2024-11-07 08:30:00 Czytaj oryginał (ang.)
Here's Why Teleflex (TFX) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-11-05 12:45:27 Czytaj oryginał (ang.)
Why Teleflex (TFX) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-11-01 12:46:27 Czytaj oryginał (ang.)
Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments. zacks.com 2024-11-01 10:31:09 Czytaj oryginał (ang.)
Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript Teleflex Incorporated (NYSE:TFX ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group David Turkaly - Citizens JMP Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Kristen Stewart - CL King Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and will be available on the company's website for replay shortly. seekingalpha.com 2024-10-31 18:43:06 Czytaj oryginał (ang.)
Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-10-31 12:36:35 Czytaj oryginał (ang.)
Teleflex (TFX) Surpasses Q3 Earnings Estimates Teleflex (TFX) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.64 per share a year ago. zacks.com 2024-10-31 10:46:14 Czytaj oryginał (ang.)
Teleflex beats quarterly profit estimates on robust medical devices demand Surgical equipment maker Teleflex reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices. reuters.com 2024-10-31 09:33:31 Czytaj oryginał (ang.)
Teleflex Announces Quarterly Dividend WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 16, 2024, to shareholders of record at the close of business on November 15, 2024. globenewswire.com 2024-10-31 08:45:00 Czytaj oryginał (ang.)
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 29, 2024. globenewswire.com 2024-10-31 08:30:00 Czytaj oryginał (ang.)
First Patient Enrolled in Teleflex's Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT) Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. globenewswire.com 2024-10-29 08:30:00 Czytaj oryginał (ang.)
TFX Stock to Gain From Launch of New Vascular Access Devices in Canada Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada. zacks.com 2024-10-28 12:20:41 Czytaj oryginał (ang.)
Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-10-24 15:05:49 Czytaj oryginał (ang.)